Characteristic | Number (%) |
---|---|
Gender, males | 21 (57) |
Gestational age at birth | |
23–24 weeks | 9 (24) |
25–26 weeks | 17 (46) |
27 weeks | 11 (30) |
Foetal growth restriction | 7 (19) |
Antenatal betamethasone | 33 (89) |
Chorioamnionitis (n=35) | 5 (14) |
Caesarean section | 15 (41) |
Apgar score 1 min <7 (n=36) | 24 (67) |
Apgar score 5 min <7 (n=36) | 10 (28) |
Surfactant treated | 23 (62) |
Patent ductus arteriosus, treated* | 23 (62) |
Retinopathy of prematurity, grade 3–4 (n=34) | 9 (26) |
Septicaemia, verified or suspected | 14 (38) |
Days in continuous positive airway pressure (CPAP) | |
<30 | 8 (22) |
30–60 | 15 (41) |
>60 | 14 (38) |
Mechanical ventilation | 29 (78) |
>7 days | 13 (35) |
Postnatal steroids, by inhalation or systemic | 22 (59) |
Bronchopulmonary dysplasia | 24 (67) |
severe | 12 (32) |
moderate | 11 (30) |
none or mild | 14 (38) |
Discharged with oxygen supplementation | 12 (32) |
*By surgical closure or indomethacin.